标题 |
Molecular Risk Stratification and Treatment Timing in LVSI-Positive Disease
LVSI阳性疾病的分子风险分层和治疗时机
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
Citation: Kim H, et al. "Molecular Risk Stratification and Treatment Timing in LVSI-Positive Disease" Clinical Cancer Research, 2023. Journal: Clinical Cancer Research Impact Factor (2023): 8.911 Key findings: Main conclusion: Early intervention particularly beneficial in high molecular risk cases Relevant statistics: 65% reduction in distant metastasis Methodology: Prospective molecular-clinical correlation study (n=423) Clinical implications: Enables better patient stratification for treatment urgency |
求助人 | |
下载 | 暂无链接,等待应助者上传 |